Perspectives
Erythropoietin and cancer - a poorly understood liaison!
Abstract
Human recombinant erythropoietin (rhEpo) has been used for many years to treat chemotherapy and cancer associated anemia. The application of rhEpo resulted in an improved quality of life of patients and in a sparing of blood transfusions (1).